Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells. (4th November 2015) - Lepone, Lauren; Donahue, Renee; Grenga, Italia; Jochems, Caroline; Tsang, Kwong-Yok; Metenou, Simon; Richards, Jacob; Heery, Christopher R; Madan, Ravi; Gulley, James L; Schlom, Jeffrey